Filing Details

Accession Number:
0001415889-22-004847
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-11 16:52:15
Reporting Period:
2022-05-10
Accepted Time:
2022-05-11 16:52:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
842023 Bio-Techne Corp TECH Biological Products, (No Disgnostic Substances) (2836) 411427402
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1258704 V Robert Baumgartner 614 Mckinley Pl N E
Minneapolis MN 55413
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-10 300 $352.55 10,106 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (Right to Buy) $255.69 2021-10-28 2030-10-29 1,507 1,507 Direct
Common Stock Stock Options (Right to Buy) $515.24 2031-10-28 633 633 Direct
Common Stock Stock Options (Right to Buy) $101.19 2017-10-26 2026-10-26 3,985 3,985 Direct
Common Stock Stock Options (Right to Buy) $125.05 2018-10-25 2027-10-26 3,125 3,125 Direct
Common Stock Stock Options (Right to Buy) $179.84 2019-10-24 2028-10-25 1,898 1,898 Direct
Common Stock Stock Options (Right to Buy) $201.64 2020-10-24 2029-10-24 2,011 2,011 Direct
Common Stock Stock Options (Right to Buy) $91.78 2014-10-30 2024-10-30 4,000 4,000 Direct
Common Stock Stock Options (Right to Buy) $87.34 2016-10-29 2025-10-28 4,260 4,260 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2030-10-29 1,507 1,507 Direct
2031-10-28 633 633 Direct
2026-10-26 3,985 3,985 Direct
2027-10-26 3,125 3,125 Direct
2028-10-25 1,898 1,898 Direct
2029-10-24 2,011 2,011 Direct
2024-10-30 4,000 4,000 Direct
2025-10-28 4,260 4,260 Direct
Footnotes
  1. The option vests on the earlier of the one year anniversary of the grant date (10/28/21) or the date of Bio-Techne's 2022 annual meeting of shareholders.